TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,391,605 | -19.9% | 2,125,500 | -15.9% | 0.10% | -23.3% |
| Q1 2023 | $41,674,575 | -4.0% | 2,528,797 | -9.1% | 0.13% | -12.8% |
| Q4 2022 | $43,410,120 | +103.9% | 2,782,700 | +114.1% | 0.15% | +57.4% |
| Q3 2021 | $21,292,000 | -8.1% | 1,299,900 | -5.6% | 0.09% | -9.6% |
| Q2 2021 | $23,175,000 | +95.5% | 1,377,000 | +111.4% | 0.10% | +79.3% |
| Q4 2020 | $11,854,000 | +157.6% | 651,300 | +143.4% | 0.06% | +107.1% |
| Q3 2019 | $4,602,000 | -76.9% | 267,562 | -72.6% | 0.03% | -68.9% |
| Q1 2019 | $19,892,000 | – | 976,514 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |